Global Biodefense December 20, 2018
The nature of Ebola outbreaks is changing as the virus finds its way out of rural villages into populous urban settings. Outbreak response experts at the WHO and GAVI are already talking to the leading Ebola vaccine manufacturer, Merck, to reassess just how much larger global stocks need to be. Besides Merk’s vaccine, another potential vaccine being developed by Johnson & Johnson could also eventually become part of the stockpile, global health officials say… read more.
Credit: NIAID